MetaADEDB 2.0 @ LMMD
Oxymetholone
(ICMWWNHDUZJFDW-DHODBPELSA-N)
Structure
SMILES
O/C=C\1/C[C@@]2(C)[C@H](CC1=O)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@]2(C)O)C
Type(s)
Approved; Illicit
ATC code(s)
A14AA05
Molecular Formula:
C21H32O3
Molecular Weight:
332.477
Log P:
4.4010
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
2
TPSA:
57.53
CAS Number(s):
434-07-1
Synonym(s)
1.
Oxymetholone
2.
Hydroxymetholone
3.
Anadrol
4.
Anapolon 50
5.
Oxymethalone
6.
Oxymetholone, (17 beta)-Isomer
7.
Oxymetholone, (5 alpha,17 alpha)-Isomer
External Link(s)
MeSHD010110
PubChem Compound5281034
BindingDB50248303
ChEBI7864
CHEMBLCHEMBL1200585
DrugBankDB06412
DrugCentral2033
KEGGcpd:C07393
dr:D00490
Therapeutic Target DatabaseD0Q6NZ
ZINC118912450
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Alanine Aminotransferase IncreasedFAERS: 2US FAERS
2Aspartate Aminotransferase IncreasedFAERS: 2US FAERS
3HepatotoxicityFAERS: 2US FAERS
4Abdominal AbscessFAERS: 1US FAERS
5AnorexiaFAERS: 1US FAERS
6Back PainFAERS: 1US FAERS
7Blood alkaline phosphatase increasedFAERS: 1US FAERS
8Drug ineffectiveFAERS: 1US FAERS
9FatigueFAERS: 1US FAERS
10Febrile NeutropeniaFAERS: 1US FAERS
11Gamma-Glutamyltransferase IncreasedFAERS: 1US FAERS
12General physical health deteriorationFAERS: 1US FAERS
13Hepatic necrosisFAERS: 1SIDER
US FAERS
14MalaiseFAERS: 1US FAERS
15Monocyte percentage increasedFAERS: 1US FAERS
16PyomyositisFAERS: 1US FAERS
17Reticuloendothelial dysfunctionFAERS: 1US FAERS
18Skin lesionFAERS: 1US FAERS
19Splenic RuptureFAERS: 1US FAERS
20Traumatic liver injuryFAERS: 1US FAERS
21Vascular purpuraFAERS: 1US FAERS
22VomitingFAERS: 1SIDER
US FAERS
23Weight decreasedFAERS: 1US FAERS
24White blood cell count decreasedFAERS: 1US FAERS
25jaundiceFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
26Acidosis, Respiratory15849280CTD
27AcneCanada Vigilance: 1Canada Vigilance
SIDER
28Acute kidney injury15849280CTD
29Alkalosis15849280CTD
30AlopeciaSIDER
31Androgenetic AlopeciaSIDER
32AzoospermiaSIDER
33Chemical and Drug Induced Liver Injury4117807CTD
34ChillsSIDER
35Cholestasis4117807CTD
36Disturbance in sexual arousalSIDER
37EpididymitisSIDER
38Erectile dysfunctionSIDER
39Heart Diseases16046796CTD
40Hemoglobinuria, Paroxysmal48615CTD
41Hemosiderosis4117807CTD
42Hepatomegaly4117807CTD
43HirsutismSIDER
44Hypernatremia15849280CTD
45Hypokalemia15849280CTD
46Insulin Resistance19356374CTD
47Liver neoplasms25058030CTD
48Malignant transformationSIDER
49Multiple Myeloma183029CTD
50NauseaCanada Vigilance: 1Canada Vigilance
SIDER
51OligospermiaSIDER
52Pancytopenia1247773
4117807
CTD
53Peliosis HepatisSIDER
54Polycythemia1247773CTD
55PriapismSIDER
56Rash erythematousCanada Vigilance: 1Canada Vigilance
57Vertigo10496122CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120242

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.